TMA-2

TMA-2

TMA-2

Psychoactive Research chemicals are new synthetic substances that are structurally similar to the original drug, while being functional analogs. Research on the effects of, and treatment for, abuse of these drugs is limited due to the fact that they’re fairly new and have avoided mainstream notice. Research chemicals do not have a lot of human consumption data, and thus harm-reduction and special care should be taken if choosing to ingest them.

Psychedelics are drugs which cause profound changes in a one’s perceptions of reality, otherwise known as hallucinations. While under the influence of hallucinogens, users might see images, hear sounds or feel sensations. These chemicals offer some of the most intense psychological experiences and care should be taken when ingesting them.

Experimental drugs have extremely limited human consumption data. There is not enough reliable information about this substance. This is most likely because the substance is is not very old. Information on these substances is limite and incomplete. Please be cautioned. Always practice harm reduction.

Disclaimer: Psychedelic drugs offer some of the most power and intense psychological experiences. Additionally these substances are illegal in many places. We understand that even though these substances are illegal, their use occurs frequently. We do not condone breaking of the law. By providing accurate information about these substances, we encourage the user to make responsible decisions and practice harm reduction.

Read the full disclaimer here.

Practice Harm Reduction. Proceed with Caution.

Description

TMA-2

Also known as:

  • 1-(2,4,5-Trimethoxyphenyl)-2-aminopropane
  • 1-(2,4,5-Trimethoxyphenyl)-2-propanamin[German][ACD/IUPAC Name]
  • 1-(2,4,5-Trimethoxyphenyl)-2-propanamine[ACD/IUPAC Name]
  • 1-(2,4,5-Triméthoxyphényl)-2-propanamine[French][ACD/IUPAC Name]
  • 1-(2,4,5-trimethoxyphenyl)propan-2-amine
  • 2,4,5-trimethoxyamphetamine
  • Benzeneethanamine, 2,4,5-trimethoxy-α-methyl-[ACD/Index Name]
  • Benzeneethanamine, 2,4,5-trimethoxy-α-methyl-, (±)-
  • Phenethylamine, 2,4,5-trimethoxy-α-methyl-
  • Phenethylamine, α-methyl-2,4,5-trimethoxy-
  • (±)1-Methyl-2-(2,4,5-trimethoxy-phenyl)-ethylamine
  • 1-Methyl-2-(2,4,5-trimethoxyphenyl)ethylamine
  • 1-Methyl-2-(2,4,5-trimethoxy-phenyl)-ethylamine
  • 1-Methyl-2-(2,4,5-trimethoxy-phenyl)-ethylamine(2,4,5-TMA)
  • 2,4,5-trimethoxy-?-methyl-benzeneethanamine
  • 2,4,5-TRIMETHOXYAMPHETAMIN
  • 2,4,5-TRIMETHOXYAMPHETAMIN, >99% (HPLC)
  • 2,4,5-TRIMETHOXYAMPHETAMINE, DL-
  • 2,4,5-trimethoxy-α-methyl-benzeneethanamine
  • 2,4,5-trimethoxy-α-methyl-benzeneethanamine
  • 2,4,5-Trimethoxy-α-methylbenzeneethanamine
  • 2,4,5-Trimethoxy-α-methylphenethylamine
  • 2,4,5-Trimethoxy-α-methylphenethylamine
  • amphetamine, 2,4,5-trimethoxy-
  • BENZENEETHANAMINE,2,4,5-TRIMETHOXY-A-METHYL-
  • Benzeneethanamine,2,4,5-trimethoxy-a-methyl-,hydrochloride (1:1)
  • Benzeneethanamine,2,4,5-trimethoxy-α-methyl-(±)-
  • MFCD01707971
  • Phenethylamine, 2,4,5-trimethoxy-α-methyl-
  • Phenethylamine, α-methyl-2,4,5-trimethoxy-
  • TMA-2

Trimethoxyamphetamine-2, a psychedelic amphetamine and stimulant first synthesised by Alexander Shulgin. An uncommon compound of similar activity to other psychedelic amphetamines. Short history of human use.

Summary

TMA-2 along with TMA-6 and others are members of the trimethoxylated family of phenethylamines. Members in this family been observed to produce a complex mixture of hallucinogenic, stimulant, psychedelic and entactogenic effects that qualitatively separates it from other psychedelic phenethylamine compounds like members of the 2C-x or DOx series. TMA-2 was first synthesized by Viktor Bruckner in 1933, but was not investigated as a psychoactive chemical until Alexander Shulgin synthesized and tested it in 1962.

Shulgin published his synthesis and initial research findings in a 1964 paper, describing the effects as similar to mescaline, though lacking in color effects, producing less nausea and prone to causing anxiety and restlessness. . There are occasional references to the use of TMA-2 in early 1970’s counter-culture publications, describing the drug as being rarely produced for sale and expensive in comparison to LSD.

This suggests that there was only very limited human usage of TMA-2 between its invention and the publication of its synthesis and pharmacology in Shulgin’s 1991 book PiHKAL (“Phenethylamines I Have Known And Loved”). Since then it has been regarded as an oddball and a novelty in the psychedelics community and is only occasionally sought after intentionally. In terms of its subjective effects, it is known for its lack of classic psychedelic visuals compared to its parent compound (mescaline) and is known instead for its instead a unique stimulating body-high and altered headspace that ranges from euphoric to dysphoric variably.

Anecdotal reports suggest that TMA-2 is a highly unpredictable and dose-sensitive substance that can produce uncomfortable amounts of body load, nausea, overstimulation, and inconsistencies between experiences. In modern times, TMA-2 is used as an obscure recreational drug and a occasional entheogen. It is rarely sold on the streets and is almost exclusively obtainable as a grey area research chemical through the use of online vendors.

History

Chemistry

TMA-2

TMA-2

Amphetamines are substituted phenethylamines, being comprised of a phenyl ring bound to an amino (NH2) group through an ethyl chain and a methyl group bound to the alpha carbon Rα.

TMA-2 contains methoxy functional groups CH3O- attached to carbons R2 and R4 and R5 of the amphetamine backbone.

Common Name2,4,5-trimethoxyamphetamine
Systematic name2,4,5-trimethoxyamphetamine
FormulaC_{12}H_{19}NO_{3}
SMILESCC(Cc1cc(c(cc1OC)OC)OC)N
Std. InChiInChI=1S/C12H19NO3/c1-8(13)5-9-6-11(15-3)12(16-4)7-10(9)14-2/h6-8H,5,13H2,1-4H3
Std. InChiKeyTVSIMAWGATVNGK-UHFFFAOYSA-N
Avg. Mass225.2842 Da
Molecular Weight225.2842
Monoisotopic Mass225.13649 Da
Nominal Mass225
ChemSpider ID28773

Subscribe for the latest updates

Dosing Guide

Oral
Threshold5-10mg
Light10-20mg
Common20-40mg
Strong40-60mg+

Duration

TMA-2 Duration Data
Onset20-120 minutes
Duration6-12 hours
After-effectsPossibility hours

Interactions and Synergies

There are no existing interaction or synergy data for this drug.

General Information

Experiences
Oral
Vaporization
Come up
Dosage
EffectsEuphoria, empathy, insight, brightened colour, Closed/Open eye visuals, enhanced tactile sensation, mental/physical stimulation, decreased appetite, pupil dilation, restlessness, change in perception, ego softening, sweating/chills, muscle tension, confusion, insomnia.
After Effects
Avoid
Warning
Risks
Test Kits
Marguis Test Result
Tolerance
Detection
Half-life
Advice
Note
Note 2:
Note 3:

Effects

Pharmacological Effects

TMA-2’s psychedelic effects are believed to come from its efficacy at the 5-HT2A receptor as a partial agonist. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

Subjective Effects

Physical Effects

  • Stimulation - In terms of its effects on the physical energy levels of the user, TMA-2 is usually considered to be extremely stimulating at levels which do not become overwhelming, resulting in a shakiness and unsteadiness of the hands but encouraging one to move around, run, dance, climb and generally engage in physical activities. In comparison, other more commonly used psychedelics such as psilocin are generally sedating and relaxed.
  • Spontaneous bodily sensations - The "body high" of TMA-2 is manifested as somewhat intense in comparison to most classical psychedelics such as LSD. The sensation itself can be described as a constantly present yet somewhat mild energetic pins and needles sensation that encompasses a person’s entire body. It is usually felt over every square inch of the skin, but occasionally manifests itself in the form of a continuously shifting tingling sensation that travels up and down the body in spontaneous waves.
  • Tactile enhancement - Feelings of enhanced tactile sensation are consistently present at moderate levels throughout most TMA-2 trips.
  • Nausea - Mild to extreme nausea is reported when consumed in moderate to high dosages and either passes once the person has vomited or gradually fades by itself as the peak sets in.
  • Vasoconstriction - This effect is usually only present at higher dosages, but can be particularly uncomfortable.
  • Bodily control enhancement
  • Pupil dilation
  • Increased blood pressure

Psychological Effects

The cognitive effects of TMA-2 are described as powerful mental stimulation along with undertones of intoxication that can increase the connectivity and rate of conceptual thinking without being overwhelming. The total sum of these cognitive components regardless of the setting generally includes:

Visual Effects

Enhancements

Distortions

Auditory Effects

Sensory Effects

Transpersonal Effects

Legal Status

  • Austria: TMA-2 is illegal to possess, produce and sell under the SMG (Suchtmittelgesetz Österreich).
  • Germany: TMA-2 is controlled under Anlage I BtMG (Narcotics Act, Schedule I) as of October 10, 1999. It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license.
  • Switzerland: TMA-2 is a controlled substance in Switzerland.

  • References

    1. Bruckner, V. (1933), Über das Pseudonitrosit des Asarons. J. Prakt. Chem., 138: 268–274. doi:10.1002/prac.19331380907 | http://onlinelibrary.wiley.com/doi/10.1002/prac.19331380907/abstract
    2. Shulgin, Alexander. "Pharmacology Lab Notes #1". Lafayette, CA. (1960-1976). p54 (Erowid.org) | https://erowid.org/library/books_online/shulgin_labbooks/shulgin_labbook1_searchable.pdf
    3. Shulgin, A.T. Experientia (1964) 20: 366. doi:10.1007/BF02147960 | https://erowid.org/archive/rhodium/chemistry/shulgin.meo-34-dialkoxyamphetamines.html
    4. 'Acidman'. "Straight Dope". Berkeley Tribe, December 18-25, 1970 p23 (Independent Voices) | http://voices.revealdigital.com/cgi-bin/independentvoices?a=d&d=BFBJFGJ19701218.1.23
    5. Lampe, Matt. "Dope-O-Scope". Ann Arbor Sun, November 12-25, 1971, p16 (Independent Voices) | http://voices.revealdigital.com/cgi-bin/independentvoices?a=d&d=BFBJFGJ19701218.1.23
    6. https://www.erowid.org/library/books_online/pihkal/pihkal162.shtml
    7. "Dreizehnte Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften" (in German). Bundesanzeiger Verlag. Retrieved December 11, 2019.
    8. "Anlage I BtMG" (in German). Bundesministerium der Justiz und für Verbraucherschutz. Retrieved December 11, 2019.
    9. "§ 29 BtMG" (in German). Bundesministerium der Justiz und für Verbraucherschutz. Retrieved December 11, 2019.
    10. https://www.admin.ch/opc/de/classified-compilation/20101220/index.html

    Sources

    Information made possible with:

    1. PsychonautWiki is a community-driven online encyclopedia that aims to document the field of psychonautics in a comprehensive, scientifically-grounded manner.
    2. Erowid is a non-profit educational & harm-reduction resource with 60 thousand pages of online information about psychoactive drugs
    3. PubChem National Center for Bio Informatics
    4. Chemspider is a free chemical structure database providing fast access to over 34 million structures, properties and associated information.
    5. Wikipedia

    Additional APIs were used to construct this information. Thanks for ChemSpider, NCBI, PubChem etc.

    Data is constantly updated so please check back later to see if there is any more available information on this substance.